Adicet Bio to Participate in a Fireside Chat at the 2024 Jefferies Healthcare Conference

Rhea-AI Summary

Adicet Bio (Nasdaq: ACET), a clinical-stage biotech firm, announced that its CEO, Chen Schor, will participate in a fireside chat at the Jefferies Healthcare Conference in New York. The event is scheduled for June 5, 2024, at 1:00 p.m. ET. Adicet specializes in allogeneic gamma delta T cell therapies targeting autoimmune diseases and cancer. The live audio webcast and a 30-day archived replay will be accessible on Adicet Bio's website.

Positive

• CEO Chen Schor's participation in the Jefferies Healthcare Conference may increase visibility and investor interest.
• Opportunity to showcase Adicet's gamma delta T cell therapies for autoimmune diseases and cancer to a broad audience.

Negative

• The press release lacks detailed information about any new clinical data or business developments, which may be seen as a missed opportunity to provide substantial updates.
• Absence of financial performance data or future projections could be perceived as a lack of transparency or progress.

REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)-- Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that Chen Schor, President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Healthcare Conference being held from June 5-6, 2024 in New York.

Details of the event are as follows:
Date: Wednesday, June 5, 2024
Time: 1:00 p.m. ET

The live audio webcast can be accessed on the Investors section of Adicet Bio’s website at http://www.adicetbio.com. An archived replay will be available for 30 days following the presentation.

About Adicet Bio, Inc.

Adicet Bio, Inc. is a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. For more information, please visit our website at https://www.adicetbio.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240529302537/en/

Adicet Bio, Inc.

Investor and Media Contacts

Anne Bowdidge

abowdidge@adicetbio.com

Janhavi Mohite

Precision AQ

212-362-1200

janhavi.mohite@precisionaq.com

Source: Adicet Bio, Inc.

FAQ

When will Adicet Bio participate in the Jefferies Healthcare Conference?

Adicet Bio will participate in the Jefferies Healthcare Conference on June 5, 2024.

Who will represent Adicet Bio at the Jefferies Healthcare Conference?

Chen Schor, President and CEO of Adicet Bio, will represent the company.

How can I access the live webcast of Adicet Bio's presentation at the Jefferies Healthcare Conference?

The live audio webcast can be accessed on the Investors section of Adicet Bio’s website.

Will there be an archived replay of Adicet Bio's fireside chat at the Jefferies Healthcare Conference?

Yes, an archived replay will be available for 30 days following the presentation.

What is Adicet Bio's stock symbol?

Adicet Bio's stock symbol is ACET.